Mounjaro Prices in the UK: What You're Actually Paying For

Why do Mounjaro prices vary so much across UK providers?

The short answer is that providers are pricing different things. Some headline figures cover the pen only. Others fold in the consultation fee, prescription charge and delivery. When Eli Lilly adjusted its UK supply price from 1 September 2025, the highest-dose pen's list price moved from around £122 to around £330, and private providers absorbed or passed on that increase in different ways. The result is a market where two quotes that look similar can represent very different levels of service.

Dose also drives the number significantly. A starter pen at 2.5mg costs far less than a 15mg maintenance pen, so a price quoted early in treatment looks nothing like what you might pay six months in. If you want to understand what the journey actually costs, it helps to look at what each pen costs across the full dose range rather than comparing first-month figures alone.

There is also a geographical element: NHS access to Mounjaro is rolling out in phases under NICE's recommendation (TA1026), and private prices partly reflect the fact that many people are not yet eligible for the NHS route or simply prefer not to wait. Understanding where you stand helps frame whether the private cost represents value.

What do Mounjaro headline prices often leave out?

This is the part that catches people out. A low headline figure often excludes some or all of the following: the consultation fee (which can run to £30–£50 separately), the prescription charge, delivery, and any clinical support if something goes wrong or a dose change is needed. Aftercare, in particular, is easy to strip out of a price and hard to notice it is missing until you need it.

There is also the question of clinical depth. A genuine consultation involves identity verification, weight confirmation and a review of your medical history by a qualified prescriber. Some services shortcut this. Starter-dose pricing can look appealing until you factor in what happens at the first dose increase and whether a clinician is involved at that point at all.

The NHS warns consumers to buy medicines only from pharmacies registered with the General Pharmaceutical Council. You can check any pharmacy, including ours, at the GPhC register — nume's registration number is 9012878. If a seller cannot point you to a GPhC premises number, that is worth pausing over.

What does the price at nume include, and why aren't we the cheapest?

We are not going to win a price comparison. That is a deliberate choice. One price at nume covers the clinical consultation, the prescription, the treatment, and free next-working-day delivery by DPD in plain packaging. There are no add-on fees and no subscription that rolls on without your input. Every repeat order is reviewed by a real prescriber before it is approved, a named clinician reads your notes, not software. Our prescribers and their approach are described on our clinical team page if you want to understand who is doing that reviewing.

We set the price this way because a weight-management medicine that is not monitored properly is not being used properly. The clinical infrastructure is part of the product. Stripping it out to post a lower number on a comparison site would be straightforward enough, but it would also be the wrong thing to do. You can see what treatment costs and check your eligibility directly on our treatment page.

Current pricing by dose is laid out there too. Those moving from their starting dose will find it useful to review what 5mg Mounjaro costs at this stage of treatment, and once titration continues, the pricing picture for 7.5mg Mounjaro is worth checking before that next prescription. For context on how the September 2025 list-price increase affected what providers charge, this page covers the updated pricing picture in detail.

Is cheaper Mounjaro ever a red flag?

Sometimes, yes. The MHRA has issued multiple warnings about counterfeit weight-loss pens sold online and through social media. In October 2025, enforcement teams raided a site in Northampton that was manufacturing fake tirzepatide pens, and by that point roughly 20 million doses of illegally traded weight-loss medicines had been seized, with an estimated street value around £45m. Some counterfeit pens have contained insulin, which has led to serious harm.

The pattern is consistent: prices well below the market rate, sellers who cannot verify a GPhC registration, no clinical assessment involved. A discount on a prescription medicine is not the same as a deal on a train ticket. You can report a suspect seller directly through the MHRA's Yellow Card scheme.

For people genuinely concerned about cost, the better question is whether NHS access might now apply to them. The NHS rollout is phased, and the price-increase and access picture is worth understanding in full. Private treatment through a registered pharmacy remains the clearest route for those who do not yet meet NHS criteria or who prefer not to wait for a referral.